These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 1976763

  • 41. Propranolol in the treatment of neuroleptic-induced akathisia.
    Lipinski JF, Zubenko GS, Cohen BM, Barreira PJ.
    Am J Psychiatry; 1984 Mar; 141(3):412-5. PubMed ID: 6142657
    [Abstract] [Full Text] [Related]

  • 42. Tardive akathisia: an analysis of clinical features and response to open therapeutic trials.
    Burke RE, Kang UJ, Jankovic J, Miller LG, Fahn S.
    Mov Disord; 1989 Mar; 4(2):157-75. PubMed ID: 2567492
    [Abstract] [Full Text] [Related]

  • 43. A rating scale for drug-induced akathisia.
    Barnes TR.
    Br J Psychiatry; 1989 May; 154():672-6. PubMed ID: 2574607
    [Abstract] [Full Text] [Related]

  • 44. Noradrenergic effects in tardive dyskinesia, akathisia and pseudoparkinsonism via the limbic system and basal ganglia.
    Wilbur R, Kulik FA, Kulik AV.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 May; 12(6):849-64. PubMed ID: 2907387
    [Abstract] [Full Text] [Related]

  • 45. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
    Brown KW, White T.
    Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
    [Abstract] [Full Text] [Related]

  • 46. Short-term changes in iron, ferritin, total iron-binding capacity, and transferrin in serum after myocardial infarction.
    Finlayson J, Fraser CG.
    Clin Chem; 1985 May; 31(5):782-3. PubMed ID: 3987011
    [No Abstract] [Full Text] [Related]

  • 47. The present status of akathisia.
    Ayd FJ.
    J Nerv Ment Dis; 1992 Mar; 180(3):208-10. PubMed ID: 1350304
    [No Abstract] [Full Text] [Related]

  • 48. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN, Shelton MD, Baker RW, Schooler NR, Baird J, Delaney J.
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [Abstract] [Full Text] [Related]

  • 49. Iron status in schizophrenic patients with acute neuroleptic-induced dystonic reactions.
    Spina E, Ancione M, Di Rosa AE, Artemisia A, Natoli C, Caputi AP.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Sep; 18(5):891-8. PubMed ID: 7972859
    [Abstract] [Full Text] [Related]

  • 50. Distinguishing akathisia and tardive dyskinesia: a review of the literature.
    Munetz MR, Cornes CL.
    J Clin Psychopharmacol; 1983 Dec; 3(6):343-50. PubMed ID: 6139392
    [Abstract] [Full Text] [Related]

  • 51. [Drug-induced akathisia].
    van Harten PN.
    Ned Tijdschr Geneeskd; 2002 Jan 19; 146(3):110-4. PubMed ID: 11826669
    [Abstract] [Full Text] [Related]

  • 52. Iron and akathisia.
    Sachdev P.
    J Neurol Neurosurg Psychiatry; 1992 Dec 19; 55(12):1221-2. PubMed ID: 1362213
    [No Abstract] [Full Text] [Related]

  • 53. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study.
    Sachdev P.
    Aust N Z J Psychiatry; 2004 Jun 19; 38(6):445-9. PubMed ID: 15209837
    [Abstract] [Full Text] [Related]

  • 54. Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia: a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use.
    Lévy E, Margolese HC, Annable L, Chouinard G.
    Can J Psychiatry; 2004 Jun 19; 49(6):398-402. PubMed ID: 15283536
    [Abstract] [Full Text] [Related]

  • 55. Tardive Akathisia with Asymmetric and Upper-body Presentation: Report of Two Cases and Literature Review.
    Shahidi G, Rohani M, Munhoz RP, Akhoundi FH.
    Tremor Other Hyperkinet Mov (N Y); 2018 Jun 19; 8():563. PubMed ID: 29971200
    [Abstract] [Full Text] [Related]

  • 56. Tardive dyskinesia and iron status.
    Chong SA, Mythily, Remington G.
    J Clin Psychopharmacol; 2004 Apr 19; 24(2):235-6. PubMed ID: 15206676
    [No Abstract] [Full Text] [Related]

  • 57. Propranolol in the treatment of tardive akathisia: a report of two cases.
    Yassa R, Iskandar H, Nastase C.
    J Clin Psychopharmacol; 1988 Aug 19; 8(4):283-5. PubMed ID: 2905362
    [Abstract] [Full Text] [Related]

  • 58. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
    Levin H, Chengappa KN, Kambhampati RK, Mahdavi N, Ganguli R.
    J Clin Psychiatry; 1992 Jul 19; 53(7):248-51. PubMed ID: 1353492
    [Abstract] [Full Text] [Related]

  • 59. Is akathisia a forerunner of tardive dyskinesia? A clinical report with brief review of literature.
    Goswami U, Channabasavanna SM.
    Clin Neurol Neurosurg; 1984 Jul 19; 86(2):107-10. PubMed ID: 6329575
    [Abstract] [Full Text] [Related]

  • 60. Drug-induced movement disorders in institutionalised adults with mental retardation: clinical characteristics and risk factors.
    Sachdev P.
    Aust N Z J Psychiatry; 1992 Jun 19; 26(2):242-8. PubMed ID: 1353672
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.